An Integrated Clinical-MR Radiomics Model to Estimate Survival Time in Patients With Endometrial Cancer.

ABSTRACT:

Background

Determination of survival time in women with endometrial cancer using clinical features remains imprecise. Features from MRI may improve the survival estimation allowing improved treatment planning.

Purpose

To identify clinical features and imaging signatures on T2-weighted MRI that can be used in an integrated model to estimate survival time for endometrial cancer subjects.

Study type

Retrospective.

Population

Four hundred thirteen patients with endometrial cancer as training (N = 330, 66.41 ± 11.42 years) and validation (N = 83, 67.60 ± 11.89 years) data and an independent set of 82 subjects as testing data (63.26 ± 12.38 years).

Field strength/sequence

1.5-T and 3-T scanners with sagittal T2-weighted spin echo sequence.

Assessment

Tu

SUBMITTER: Li X 

PROVIDER: S-EPMC10947322 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature